Comparative studies have found that VEGF-A, VEGF-C, and VEGF-D expression levels are higher in gastric cancer and precancerous lesions than in normal tissues, with the highest levels in gastric cancer tissues. This evidence concerns the gene VEGFD and gastric cancer.